Safe-Infusion Study
A Non-Inferiority Randomized Clinical Trial Investigating Efficacy and Safety of an Innovative Medical Device in the Reduction of Mechanical Complications of Peripheral Intravenous Catheters
Interlinked AB
548 participants
Mar 25, 2024
INTERVENTIONAL
Conditions
Summary
Around 1.5 billion peripheral intravenous catheters (PIVCs) are sold yearly, with up to 90% of hospitalized patients receiving one, yet failure rates can reach 69%, often due to phlebitis, infiltration, occlusion, or dislodgement. These complications can collectively be named mechanical complications. This study aims to assess a new device's effectiveness in reducing mechanical complications associated with PIVCs through a non-inferiority randomized trial at two sites. A total of 548 patients will be recruited, with primary outcomes focused on complication rates and secondary outcomes examining adverse events, healthcare feedback, and economic impacts.
Eligibility
Inclusion Criteria5
- The patient has or will get a vascular access device (VAD) expected to be used for continuous or intermittent IV infusion therapy. Continuous IV infusion is defined as an infusion ≥2h and intermitted as an infusion lasting 15min to <2h.
- ≥18 years of age
- Speak and understand local language
- VADs already in place when the patient is admitted to the ward should not present with phlebitis or infiltration or occlusion
- Participants have signed the informed consent or have a legal authorized representative (LAR) who has provided this consent
Exclusion Criteria5
- The VAD is expected to be used for sampling only
- Pregnancy
- Unable to obtain informed consent or without an available LAR to provide surrogate informed consent
- Patients under palliative care
- Bolus IV infusion, defined as an infusion time of <15 min
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The interventional device is a coupling device intended to prevent mechanical complications during peripheral intravenous infusions. While control will not receive the device.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06727240